Upcoming Pfizer Earnings Call Might Be Focused On Tariffs, Policy Risks And Obesity Pipeline - Pfizer (NYSE:PFE)

Upcoming Pfizer Earnings Call Might Be Focused On Tariffs, Policy Risks And Obesity Pipeline - Pfizer (NYSE:PFE)

Pfizer Inc (NYSE:PFE) is scheduled to release its first quarter 2025 earnings on 29 April. Analysts forecast adjusted earnings of 70 cents per share with sales of $14.26 billion. BofA updated its earnings model for 1Q25 as analyst Tim Anderson lowered total revenue estimates by -2.1%, primarily due to updated assumptions regarding the impact of Part D on the portfolio and tweaks to Paxlovid seasonality. EPS follows, decreasing by -4.9%. For 2025…

How a scrapped Pfizer drug became a winner for SpringWorks

SpringWorks Therapeutics and the Children’s Tumor Foundation salvaged a shelved asset for neurofibromatosis and got it over the regulatory finish line.